Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 55

1.

BACE1-Deficient Mice Exhibit Alterations in Immune System Pathways.

Stertz L, Contreras-Shannon V, Monroy-Jaramillo N, Sun J, Walss-Bass C.

Mol Neurobiol. 2016 Dec 21. doi: 10.1007/s12035-016-0341-1. [Epub ahead of print]

PMID:
28004339
2.

Bipolar disorder moderates associations between linoleic acid and markers of inflammation.

Chang YW, Assari S, Prossin AR, Stertz L, McInnis MG, Evans SJ.

J Psychiatr Res. 2017 Feb;85:29-36. doi: 10.1016/j.jpsychires.2016.10.021.

PMID:
27821270
3.

Perinatal complications, lipid peroxidation, and mental health problems in a large community pediatric sample.

Mansur RB, Cunha GR, Asevedo E, Zugman A, Rios AC, Salum GA, Pan PM, Gadelha A, Levandowski ML, Belangero SI, Manfro GG, Stertz L, Kauer-Sant'anna M, Miguel EC, Bressan RA, Mari JJ, Grassi-Oliveira R, Brietzke E.

Eur Child Adolesc Psychiatry. 2016 Oct 26. [Epub ahead of print]

PMID:
27785581
4.

Socioeconomic Disadvantage Moderates the Association between Peripheral Biomarkers and Childhood Psychopathology.

Mansur RB, Cunha GR, Asevedo E, Zugman A, Zeni-Graiff M, Rios AC, Sethi S, Maurya PK, Levandowski ML, Gadelha A, Pan PM, Stertz L, Belangero SI, Kauer-Sant' Anna M, Teixeira AL, Mari JJ, Rohde LA, Miguel EC, McIntyre RS, Grassi-Oliveira R, Bressan RA, Brietzke E.

PLoS One. 2016 Aug 4;11(8):e0160455. doi: 10.1371/journal.pone.0160455.

5.

BDNF Val66Met polymorphism and peripheral protein levels in pediatric bipolar disorder and attention-deficit/hyperactivity disorder.

Zeni CP, Tramontina S, Aguiar BW, Salatino-Oliveira A, Pheula GF, Sharma A, Stertz L, Moreira Maia CR, Hutz M, Kapczinski FP, Rohde LA.

Acta Psychiatr Scand. 2016 Sep;134(3):268-74. doi: 10.1111/acps.12587.

PMID:
27209073
6.

Acute White Matter Tract Damage after Frontal Mild Traumatic Brain Injury.

Herrera JJ, Bockhorst K, Kondraganti S, Stertz L, Quevedo J, Narayana PA.

J Neurotrauma. 2017 Jan 15;34(2):291-299. doi: 10.1089/neu.2016.4407.

PMID:
27138134
7.

Serum BDNF levels in unaffected first-degree relatives of patients with bipolar disorder.

Nery FG, Gigante AD, Amaral JA, Fernandes FB, Berutti M, Almeida KM, Stertz L, Bristot G, Kapczinski F, Lafer B.

Rev Bras Psiquiatr. 2016 Jul-Sep;38(3):197-200. doi: 10.1590/1516-4446-2015-1801.

8.

Ethanol during adolescence decreased the BDNF levels in the hippocampus in adult male Wistar rats, but did not alter aggressive and anxiety-like behaviors.

Scheidt L, Fries GR, Stertz L, Cabral JC, Kapczinski F, de Almeida RM.

Trends Psychiatry Psychother. 2015 Jul-Sep;37(3):143-51. doi: 10.1590/2237-6089-2015-0017.

9.

Interaction between SLC6A4 promoter variants and childhood trauma on the age at onset of bipolar disorders.

Etain B, Lajnef M, Henrion A, Dargél AA, Stertz L, Kapczinski F, Mathieu F, Henry C, Gard S, Kahn JP, Leboyer M, Jamain S, Bellivier F.

Sci Rep. 2015 Nov 6;5:16301. doi: 10.1038/srep16301.

10.

Association of serum brain-derived neurotrophic factor (BDNF) and tumor necrosis factor-alpha (TNF-α) with diagnosis of delirium in oncology inpatients.

Brum C, Stertz L, Borba E, Rumi D, Kapczinski F, Camozzato A.

Rev Bras Psiquiatr. 2015 Jul-Sep;37(3):197-202. doi: 10.1590/1516-4446-2014-1450.

11.

Inflammation, neurotrophism and oxidative stress and childhood psychopathology in a large community sample.

Cunha GR, Asevedo E, Mansur RB, Zugman A, Pan PM, Gadelha A, Belangero SI, Rizzo LB, Coelho R, Stertz L, Cogo-Moreira H, Grassi-Oliveira R, Teixeira AL, Kauer-Sant'Anna M, Mari JJ, Miguel EC, Bressan RA, Brietzke E.

Acta Psychiatr Scand. 2015 Jul 3. doi: 10.1111/acps.12453. [Epub ahead of print] Erratum in: Acta Psychiatr Scand. 2016 Dec;134(6):569-570.

PMID:
26139469
12.

Memory and brain-derived neurotrophic factor after subchronic or chronic amphetamine treatment in an animal model of mania.

Fries GR, Valvassori SS, Bock H, Stertz L, Magalhães PV, Mariot E, Varela RB, Kauer-Sant'Anna M, Quevedo J, Kapczinski F, Saraiva-Pereira ML.

J Psychiatr Res. 2015 Sep;68:329-36. doi: 10.1016/j.jpsychires.2015.05.006.

PMID:
26026487
13.

The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders.

Réus GZ, Fries GR, Stertz L, Badawy M, Passos IC, Barichello T, Kapczinski F, Quevedo J.

Neuroscience. 2015 Aug 6;300:141-54. doi: 10.1016/j.neuroscience.2015.05.018. Review.

PMID:
25981208
14.

Damage-associated molecular patterns and immune activation in bipolar disorder.

Stertz L, Fries GR, Rosa AR, Kauer-Sant'anna M, Ferrari P, Paz AV, Green C, Cunha ÂB, Dal-Pizzol F, Gottfried C, Kapczinski F.

Acta Psychiatr Scand. 2015 Sep;132(3):211-7. doi: 10.1111/acps.12417.

PMID:
25891376
15.

Mineralocorticoid receptor genotype moderates the association between physical neglect and serum BDNF.

Bortoluzzi A, Salum GA, Blaya C, Silveira PP, Grassi-Oliveira R, da Rosa ED, de Aguiar BW, Stertz L, Bosa VL, Schuch I, Goldani M, Kapczinski F, Leistner-Segal S, Manfro GG.

J Psychiatr Res. 2014 Dec;59:8-13. doi: 10.1016/j.jpsychires.2014.08.022.

PMID:
25241277
16.

Staging bipolar disorder: clinical, biochemical, and functional correlates.

Grande I, Magalhães PV, Chendo I, Stertz L, Panizutti B, Colpo GD, Rosa AR, Gama CS, Kapczinski F, Vieta E.

Acta Psychiatr Scand. 2014 Jun;129(6):437-44. doi: 10.1111/acps.12268.

PMID:
24628576
17.

Expression of matrix metalloproteinases in patients with bipolar disorder.

Chiarani F, Fries GR, Stertz L, Ceresér KM, Wyse AT, Kapczinski FP, Kunz M.

Rev Bras Psiquiatr. 2013 Oct-Dec;35(4):375-9. doi: 10.1590/1516-4446-2012-1004.

18.

Histone deacetylase activity and brain-derived neurotrophic factor (BDNF) levels in a pharmacological model of mania.

Stertz L, Fries GR, Aguiar BW, Pfaffenseller B, Valvassori SS, Gubert C, Ferreira CL, Moretti M, Ceresér KM, Kauer-Sant'Anna M.

Rev Bras Psiquiatr. 2014 Jan-Mar;36(1):39-46.

19.

Peripheral eotaxin-1 (CCL11) levels and mood disorder diagnosis in a population-based sample of young adults.

Magalhaes PV, Jansen K, Stertz L, Ferrari P, Pinheiro RT, da Silva RA, Kapczinski F.

J Psychiatr Res. 2014 Jan;48(1):13-5. doi: 10.1016/j.jpsychires.2013.10.007. No abstract available.

PMID:
24182965
20.

Val66Met polymorphism and serum brain-derived neurotrophic factor in bipolar disorder: an open-label trial.

Grande I, Magalhães PV, Chendo I, Stertz L, Fries GR, Cereser KM, Cunha ÂB, Gói P, Kunz M, Udina M, Martín-Santos R, Frey BN, Vieta E, Kapczinski F.

Acta Psychiatr Scand. 2014 May;129(5):393-400. doi: 10.1111/acps.12192.

PMID:
23957567
Items per page

Supplemental Content

Loading ...
Support Center